Heterobivalent ligands target cell-surface receptor combinations in vivo
暂无分享,去创建一个
Liping Xu | Robert J Gillies | Josef Vagner | Ronald M Lynch | Michael R Caplan | R. Gillies | V. Hruby | R. Lynch | D. Morse | J. Vagner | Liping Xu | E. Mash | David L Morse | J. Josan | M. Caplan | Eugene A Mash | Victor J Hruby | Jatinder S Josan
[1] A. Thakur,et al. Cancer therapy with bispecific antibodies: Clinical experience. , 2010, Current opinion in molecular therapeutics.
[2] Seungpyo Hong,et al. The Binding Avidity of a Nanoparticle-based Multivalent Targeted Drug Delivery Platform , 2022 .
[3] R. Gillies,et al. Cell-specific targeting by heterobivalent ligands. , 2011, Bioconjugate chemistry.
[4] Thommey P. Thomas,et al. Targeting and inhibition of cell growth by an engineered dendritic nanodevice. , 2005, Journal of medicinal chemistry.
[5] E. Bäumler. In search of the magic bullet , 1965 .
[6] G M Whitesides,et al. A trivalent system from vancomycin.D-ala-D-Ala with higher affinity than avidin.biotin. , 1998, Science.
[7] R. Gillies,et al. Design, synthesis, and biological studies of efficient multivalent melanotropin ligands: tools toward melanoma diagnosis and treatment. , 2011, Journal of medicinal chemistry.
[8] Michael R. Caplan,et al. Targeting Drugs to Combinations of Receptors: A Modeling Analysis of Potential Specificity , 2005, Annals of Biomedical Engineering.
[9] A. Eberle,et al. Characterization of Receptors for α-Melanocyte-stimulating Hormone on Human Melanoma Cells , 1989 .
[10] R. Gillies,et al. Expression-driven reverse engineering of targeted imaging and therapeutic agents , 2003, Expert opinion on therapeutic targets.
[11] A. Eberle,et al. Characterization of receptors for alpha-melanocyte-stimulating hormone on human melanoma cells. , 1989, Cancer research.
[12] M. Bentley,et al. Poly(ethylene) Glycol Conjugates of Biopharmaceuticals in Drug Delivery , 2008 .
[13] R. Gillies,et al. Solid-phase synthetic strategy and bioevaluation of a labeled delta-opioid receptor ligand Dmt-Tic-Lys for in vivo imaging. , 2009, Organic letters.
[14] Robert J Gillies,et al. Hitting multiple targets with multimeric ligands , 2004, Expert opinion on therapeutic targets.
[15] Martin A Walter,et al. Preclinical evaluation of new and highly potent analogues of octreotide for predictive imaging and targeted radiotherapy. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[16] Robert J Gillies,et al. Gene expression profiling-based identification of cell-surface targets for developing multimeric ligands in pancreatic cancer , 2008, Molecular Cancer Therapeutics.
[17] James Inglese,et al. Chemokine receptor-ligand interactions measured using time-resolved fluorescence. , 1998, Biochemistry.
[18] F. Davis,et al. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. , 1977, The Journal of biological chemistry.
[19] O. Westphal,et al. Paul Ehrlich--in search of the magic bullet. , 2004, Microbes and infection.
[20] Paul R Selvin,et al. Principles and biophysical applications of lanthanide-based probes. , 2002, Annual review of biophysics and biomolecular structure.
[21] Mouldy Sioud,et al. Selective targeting of cancer cells using synthetic peptides. , 2003, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[22] W. Clark Still,et al. An unbounded systematic search of conformational space , 1991 .
[23] Franklin Peale,et al. Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site , 2009, Science.
[24] R. Gillies,et al. Effects of linker length and flexibility on multivalent targeting. , 2008, Biomacromolecules.
[25] G. Chang,et al. Macromodel—an integrated software system for modeling organic and bioorganic molecules using molecular mechanics , 1990 .
[26] K. Palczewski,et al. Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.
[27] M. Neeman,et al. Conjugates of daidzein-alliinase as a targeted pro-drug enzyme system against ovarian carcinoma , 2011, Journal of drug targeting.
[28] Kenneth J. Hillan,et al. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer , 2004, Nature Reviews Drug Discovery.
[29] R. Gillies,et al. Enhanced targeting with heterobivalent ligands , 2009, Molecular Cancer Therapeutics.
[30] D. Scherman,et al. Liposome biodistribution by time resolved fluorimetry of lipophilic europium complexes , 2005, European Biophysics Journal.
[31] R. Gillies,et al. Heterobivalent ligands crosslink multiple cell-surface receptors: the human melanocortin-4 and delta-opioid receptors. , 2008, Angewandte Chemie.
[32] L. Kiessling,et al. Synthetic multivalent ligands in the exploration of cell-surface interactions. , 2000, Current opinion in chemical biology.
[33] N. Kotite,et al. Lysine reduces renal accumulation of radioactivity associated with injection of the [177Lu]alpha-[2-(4-aminophenyl) ethyl]-1,4,7,10-tetraaza-cyclodecane-1,4,7,10-tetraacetic acid-CC49 Fab radioimmunoconjugate. , 1995, Cancer research.
[34] M Schwaiger,et al. Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[35] George M Whitesides,et al. Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors. , 1998, Angewandte Chemie.
[36] Robert J Gillies,et al. Novel targeting strategy based on multimeric ligands for drug delivery and molecular imaging: homooligomers of alpha-MSH. , 2004, Bioorganic & medicinal chemistry letters.
[37] J. Kopeček,et al. Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells. , 2004, European journal of cancer.
[38] W. Clark Still,et al. A rapidly convergent simulation method: Mixed Monte Carlo/stochastic dynamics , 1994, J. Comput. Chem..
[39] Manfred Burghammer,et al. Structure of bovine rhodopsin in a trigonal crystal form. , 2003, Journal of molecular biology.
[40] A. Ullrich,et al. Paul Ehrlich's magic bullet concept: 100 years of progress , 2008, Nature Reviews Cancer.